Pharmaceutical

 

SwissCannaMed scientific research for natural CBN against sleep disorders

Signed research Agreement with the University ETH of Zurich.
Pharmaceutical
Focus on the most sedative cannabinoid CBN (Cannabinol), with the objective to further develop a pharmaceutical sleep-enhancing drug on a natural basis.
Project led by Professor Dr. Erick M. Carreira, a well-known scientist for his research group’s work in total synthesis projects, particularly asymmetric synthesis of complex natural products.
Research will result with patent by ETH and SwissCannaMed.

ETH Zurich, is one the World’s leading universities in science and technology, with a yearly budget of 1.9 billion Swiss francs. The ETH can count over 20 Nobel Prize, among them are Albert Einstein and Wolfgang Pauli.